Ubs Asset Management Americas Inc Axsome Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 28,841 shares of AXSM stock, worth $2.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,841
Previous 30,009
3.89%
Holding current value
$2.31 Million
Previous $2.39 Million
3.64%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AXSM
# of Institutions
290Shares Held
37.1MCall Options Held
401KPut Options Held
464K-
Rtw Investments, LP New York, NY4.49MShares$360 Million5.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$300 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.2MShares$256 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$189 Million30.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.3MShares$105 Million3.44% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.44B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...